IFTBFInfant Bacterial Therapeutics AB - Ordinary Shares - Class B

$6.18
$0.71
(12.98%)
Today
Updated: 01:24 PM EST
Mkt Cap$83.25M
Vol1.00

About

Infant Bacterial Therapeutics AB is a clinical stage pharmaceutical company, which engages in the development of drugs for the treatment of rare diseases affecting premature infants. Its products include IBP-9414 and IBP-1016. The IBP-9414, is a drug candidate contains Lactobacillus reuteri which is a human bacterial strain naturally present in breast milk that improves feeding tolerance in premature infants and IBP-1016, helps in treating gastroschisis, a severe birth defect in infants. The company was founded in 2013 and is headquartered in Stockholm, Sweden.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
8

Frequently Asked Questions

What is Market Cap of Infant Bacterial Therapeutics AB - Ordinary Shares - Class B?
What is the 52-week high for Infant Bacterial Therapeutics AB - Ordinary Shares - Class B?
What is the 52-week low for Infant Bacterial Therapeutics AB - Ordinary Shares - Class B?
What is Infant Bacterial Therapeutics AB - Ordinary Shares - Class B stock price today?
What was Infant Bacterial Therapeutics AB - Ordinary Shares - Class B stock price yesterday?
What is the PE ratio of Infant Bacterial Therapeutics AB - Ordinary Shares - Class B?
What is the Price-to-Book ratio of Infant Bacterial Therapeutics AB - Ordinary Shares - Class B?
What is the 50-day moving average of Infant Bacterial Therapeutics AB - Ordinary Shares - Class B?
How many employees does Infant Bacterial Therapeutics AB - Ordinary Shares - Class B have?

Latest IFTBF News

View
Top Discussions

Advertisement|Remove ads.